Brief: Irlab Q1 Operating Loss SEK 59.5 Mln

IRLAB Therapeutics AB

10/05/2023 06:08

May 10 (Reuters) - IRLAB Therapeutics AB  IRLABa.ST :
    * Q1 OPERATING RESULT: SEK -59.5M (SEK -29.1M)

Source text for Eikon:  ID:nMFN10Ggcd 
Further company coverage:  IRLABa.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))